COVID-19 asymptomatic transmission and reinfection

Newswise’s Thom Canalichio hosted the debate with Dr Rebecca Dutch (Professor and chair of the Department of Molecular and Cellular

SA joins the race for COVID-19 vaccine

THE VACCINE Developed at the Oxford Jenner Institute, the ChAdOx1 nCov-19 the vaccine was made by adding genetic material –

How to interpret PCT at the bedside in COVID-19 patients?

Procalcitonin has long been used as a biomarker for the detection of community-acquired pneumonia and Prof Molnár advocates its use

Asymptomatic transmission? Italian doc sets the record straight

While studies have confirmed the presence of asymptomatic disease transmission as an aspect of SARS-CoV-2‘s disease profile, the unanswered question

From confusion to ‘COVID toes’

Dr Choi says: “Confusion in elderly people is something that we see often, especially when someone is admitted to the

COVID-19: Is herd immunity a strategy for SA?

Professor Ismail Kalla, in Pulmonology in Internal Medicine, and Professor Abdullah Laher in Emergency Medicine in the School of Clinical

Wearable devices as early warning for COVID-19

Although the average is five to six days, it can take up to 14 days before symptom onset. To better

Private hospital groups at mercy of COVID-19

“Initially, there was a view that increased cases of COVID-19 infected patients would result in more admissions into hospitals, possibly

Properly managed, HIV patients not at increased risk from COVID-19

However, HIV clinician, Dr Kairoonisha “Kay” Mahomed, who runs an HIV clinic at Netcare Garden City Hospital in Johannesburg, says

Who is at greatest risk of COVID-19?

Vulnerable populations Early Covid-19 case reports suggest that patients with underlying conditions are at higher risk for complications or mortality.